This partnership would require unwavering conviction hyperopia. I am sure LP will ask strong commitment on the side of the partners. Those with intimate knowledge of what this cell therapy can do may show more commitments than others who don’t. So yes BMY is one of those early pioneer with deep resources in this area.
hyperopia, Good points regarding BMY. Long time holder of MRK subsequently added BMY along the way. Both are decent dividend and plays. Along that vein ROG.SW also appears to be a good dividend play. Additionally ROG.SW bing foreign based (Swiss) has the potential benefit of a currency play given the relative strength of the US dollar IMO.